JACIE develops and maintain global standards for the provision of quality medical and laboratory practice in cellular therapy. Based on these standards, JACIE offers accreditation to transplant programmes in order to encourage health institutions and facilities to establish and maintain quality management systems impacting on all aspects of their activities and to engage in continuous improvement.
JACIE's primary aim is to promote high quality patient care and laboratory performance in collection, processing and transplantation centres through an internationally recognised system of accreditation.
JACIE is a committee of the EBMT, and as such is part of its fiscal and legal identity. Members are appointed by and accountable to the EBMT Board. The ISCT is represented through two members of the Committee.
The European Society for Blood and Marrow Transplantation (EBMT) is a non-profit organisation based in Maastricht, The Netherlands, that was established in 1974 in order to allow scientists and physicians involved in clinical bone marrow transplantation to share their experience and develop co-operative studies. The EBMT aims to promote all aspects associated with the transplantation of haematopoietic stem cells from all donor sources and donor types including basic and clinical research, education, standardisation, quality control, and accreditation for transplant procedures.
The International Society for Cellular Therapy (ISCT), formerly ISHAGE, is the professional organization for those working or interested in cell-based research, processing, manipulation, and clinical translation. Established in 1992, the Society provides a global forum for Communication, education and training; Performance of collaborative scientific studies; Development and validation of standardised technology; Representation of the membership to other professional organizations and regulatory and governmental bodies.
Membership is over 1,100 members strong and growing internationally with membership in North America, Europe, Asia, South America, the Middle East and Africa. The organization is composed of basic and clinical researchers, technical specialists, physicians and others with experience in the area. ISCT communicates with its membership via its official journal, the Telegraft, and the organisation web site.
The ISCT mandate includes work in the following areas: Cord blood, Ex-vivo Expansion, Gene Therapy, Graft Evaluation, Immunotherapy and Dendritic Cells, Nonhematopoietic Mesenchymal Stem Cells, Transplantation, Tumor Evaluation, and Legal and Regulatory Affairs.
JACIE, as part of the EBMT, has regularly participated in projects and other initiatives. Below is a list of projects where JACIE and/or EBMT have contributed or are contributing.
ARTHIQS EU Joint Action
External Recognition from the European Union
The JACIE Accreditation Programme was supported in 2004 by the European Commission under the Public Health Programme 2003-2008 (Project No. 2003208). In a 2011 review of spending under the Public Health Programme, JACIE was highlighted as an exemplary project:
"The JACIE project is considered an outstanding example of how EU funding can facilitate the harmonisation, implementation and use of common standards. It is also outstanding in its continuing activities after the end of the project period and its success with regard to international collaboration and contribution to public health policies and regulation" (p.79)
Download the report below.
National Regulations & Guidelines
To learn more about how JACIE accreditation is implemented in and incorporated into the national regulations and guidelines of individual countries and international bodies, visit our Regulations & Guidelines page below.